Publikationen

Hier finden Sie ausgewählte Publikationen zur Gynäkologie:

Wolters R, Wischhusen J, Stüber T, Weiss CR, Krockberger M, Bartmann C, Blettner M, Janni W, Kreienberg R, Schwentner L, Novopashenny I, Wischnewsky M, Wöckel A, Diessner J (2015) Guidelines are advantageous, though not essential for improved survival among breast cancer patients. Breast Cancer Res Treat 152:357-66.

Wöckel A, Janni W, Porzsolt F, Schmutzler R (2014) Benefits and risks of breast cancer screening. Oncol Res Treat 37 Suppl 3:21-8.

Herr D, Bekes I, Wulff C (2015) Regulation of endothelial permeability in the primate corpora lutea: implications for ovarian hyperstimulation syndrome. Reproduction 149:R71-9.

Bartmann C, Segerer SE, Rieger L, Kapp M, Sütterlin M, Kämmerer U (2014) Quantification of the predominant immune cell populations in decidua throughout human pregnancy. Am J Reprod Immunol 71:109-19.

Häusler SF, Del Barrio IM, Diessner J, Stein RG, Strohschein J, Hönig A, Dietl J, Wischhusen J (2014) Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion. Am J Transl Res 6:129-39.

Publikationen 2016

Bartmann C, Junker M, Segerer SE, Häusler SF, Krockenberger M, Kämmerer U. (2016) CD33(+) /HLA-DR(neg) and CD33(+) /HLA-DR(+/-) Cells: Rare Populations in the Human Decidua with Characteristics of MDSC. Am J Reprod Immunol 75(5):539-56.

Bekes I, Friedl TW, Köhler T, Möbus V, Janni W, Wöckel A, Wulff C. (2016) Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer? Mol Cancer 15:13.

Bluemel C, Safak G, Cramer A, Wöckel A, Gesierich A, Hartmann E, Schmid JS, Kaiser F, Buck AK, Herrmann K. (2016) Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodes. Eur J Nucl Med Mol Imaging 43(13):2304-2312.

Chen W, Spitzl A, Mathes D, Nikolaev VO, Werner F, Weirather J, ?piranec K, Röck K, Fischer JW, Kämmerer U, Stegner D, Baba HA, Hofmann U, Frantz S, Kuhn M. (2016) Endothelial Actions of ANP Enhance Myocardial Inflammatory Infiltration in the Early Phase After Acute Infarction. Circ Res 119(2):237-48.

Diessner J, Wischnewsky M, Blettner M, Häusler S, Janni W, Kreienberg R, Stein R, Stüber T, Schwentner L, Bartmann C, Wöckel A. (2016) Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study. PLoS ONE 11(12):e0168730.

Diessner J, Wischnewsky M, Stüber T, Stein R, Krockenberger M, Häusler S, Janni W, Kreienberg R, Blettner M, Schwentner L, Wöckel A, Bartmann C. (2016) Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer. BMC Cancer 16:307.

Glaser K, Fehrholz M, Papsdorf M, Curstedt T, Kunzmann S, Speer CP. (2016) The new generation synthetic reconstituted surfactant CHF5633 suppresses LPS-induced cytokine responses in human neonatal monocytes. Cytokine 86:119-123.

Hamza A, Meyberg-Solomayer G, Juhasz-Böss I, Joukhadar R, Takacs Z, Solomayer EF, Baum S, Radosa J, Mavrova L, Herr D. (2016) Diagnostic Methods of Ectopic Pregnancy and Early Pregnancy Loss: a Review of the Literature. Geburtsh Frauenheilk 76(4):377-382.

Joukhadar R, Wöckel A, Herr D, Paulus V, Radosa J, Hamza A, Solomayer E, Baum S. (2016) Challenges of Longevity: Safety of Vaginal and Laparoscopic Urogynecological Procedures in Septuagenarians and Older Patients. Biomed Res Int 2016:5184595.

Klement RJ, Champ CE, Otto C, Kämmerer U. (2016) Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis. PLoS ONE 11(5):e0155050.

König J, van Ewijk R, Kuhr K, Schmidberger H, Wöckel A, Kreienberg R, Blettner M. (2016) Radiotherapy effects on early breast cancer survival in observational and randomized studies: a systematic analysis of advantages, disadvantages and differences between the two study types. Breast Cancer 23(3):415-24.

Muallem MZ, Sehouli J, Almuheimid J, Richter R, Joukhadar R, Plett H. (2016) Risk Factors of Lymph Nodes Metastases by Endometrial Cancer: A Retrospective One-center Study. Anticancer Res 36(8):4219-25.

Otto C, Hahlbrock T, Eich K, Karaaslan F, Jürgens C, Germer CT, Wiegering A, Kämmerer U. (2016) Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract. BMC Complement Altern Med 16:160.

Schlagenhauf U, Jakob L, Eigenthaler M, Segerer S, Jockel-Schneider Y, Rehn M. (2016) Regular consumption of Lactobacillus reuteri-containing lozenges reduces pregnancy gingivitis: an RCT. J Clin Periodontol 43(11):948-954.

Schmalzing M, Krockenberger M, Honig A, Tony HP. (2016) Gynecological cancers in patients with inflammatory rheumatic diseases. Z Rheumatol 75(1):63-7.

Schwentner L, Van Ewijk R, Kühn T, Flock F, Felberbaum R, Blettner M, Kreienberg R, Janni W, Wöckel A, Singer S. (2016) Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy-results from the prospective multi-center study BRENDA II. Support Care Cancer 24(6):2759-66.

Segerer SE, Bartmann C, Kaspar S, Müller N, Kapp M, Butt E, Kämmerer U. (2016) The cytoskeletal protein LASP-1 differentially regulates migratory activities of choriocarcinoma cells. Arch Gynecol Obstet 293(2):407-14.

Singer S, Schwentner L, van Ewijk R, Blettner M, Wöckel A, Kühn T, Felberbaum R, Flock F, Janni W, BRENDA Study Group. (2016) The course of psychiatric co-morbidity in patients with breast cancer--results from the prospective multi-centre BRENDA II study. Psychooncology 25(5):590-6.

Stein RG, Wollschläger D, Kreienberg R, Janni W, Wischnewsky M, Diessner J, Stüber T, Bartmann C, Krockenberger M, Wischhusen J, Wöckel A, Blettner M, Schwentner L, BRENDA Study Group. (2016) The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients. BMC Cancer 16:459.

Stüber TN, Frieauff E, Weiß C, Zollner U, Wöckel A, Meyer T, Rehn M. (2016) Prenatal sonographic ultrasound predictors for the outcome in fetal gastroschisis: a retrospective analysis. Arch Gynecol Obstet 293(5):1001-6.

Weibel S, Neubert K, Jelting Y, Meissner W, Wöckel A, Roewer N, Kranke P. (2016) Incidence and severity of chronic pain after caesarean section: A systematic review with meta-analysis. Eur J Anaesthesiol 33(11):853-865.

Weide B, Schäfer T, Martens A, Kuzkina A, Uder L, Noor S, Garbe C, Harter PN, Mittelbronn M, Wischhusen J. (2016) High GDF-15 Serum Levels Independently Correlate with Poorer Overall Survival of Patients with Tumor-Free Stage III and Unresectable Stage IV Melanoma. J Invest Dermatol 136(12):2444-2452.

Publikationen 2015

Diessner J, Van Ewijk R, Weiss CR, Janni W, Wischnewsky MB, Kreienberg R, Hancke K, Blettner M, Wöckel A, Schwentner L. (2015) Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study. Arch Gynecol Obstet 292(3):655-64.

Dietl A, Cupisti S, Beckmann MW, Schwab M, Zollner U. (2015) Pregnancy and Obstetrical Outcomes in Women Over 40 Years of Age. Geburtsh Frauenheilk 75(8):827-832.

Ebner F, Hancke K, Blettner M, Schwentner L, Wöckel A, Kreienberg R, Janni W, van Ewijk R. (2015) Aggressive Intrinsic Subtypes in Breast Cancer: A Predictor of Guideline Adherence in Older Patients With Breast Cancer? Clin Breast Cancer 15(4):e189-95.

Ebner F, van Ewijk R, Wöckel A, Hancke K, Schwentner L, Fink V, Kreienberg R, Janni W, Blettner M. (2015) Tumor biology in older breast cancer patients--what is the impact on survival stratified for guideline adherence? A retrospective multi-centre cohort study of 5378 patients. Breast 24(3):256-62.

Ebner F, Varga D, Sorg F, Vorwerk E, Schochter F, Janni W, Wöckel A, DeGregorio N. (2015) Treatment cost evaluation of extrauterine gravidity: a literature review of medical and surgical treatment costs. Arch Gynecol Obstet 291(3):493-8.

Frauenschuh I, Wirbelauer J, Karl S, Girschick G, Rehn M, Zollner U, Frambach T, Dietl J, Müller T. (2015) Prognostic factors of perinatal short-term outcome in severe placental insufficiency using Doppler sonography to assess end-diastolic absent and reverse blood flow in umbilical arteries. Z Geburtshilfe Neonatol 219(1):28-36.

Hahne JC, Kurz A, Meyer SR, Dietl J, Engel JB, Honig A. (2015) Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer. Arch Gynecol Obstet 291(1):131-41.

Harter PN, Bernatz S, Scholz A, Zeiner PS, Zinke J, Kiyose M, Blasel S, Beschorner R, Senft C, Bender B, Ronellenfitsch MW, Wikman H, Glatzel M, Meinhardt M, Juratli TA, Steinbach JP, Plate KH, Wischhusen J, Weide B, Mittelbronn M. (2015) Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases. Oncotarget 6(38):40836-49.

Heinrich T, Nanda I, Rehn M, Zollner U, Ernestus K, Wirth C, Schlüter G, Schmid M, Kunstmann E. (2015) Co-Occurence of Reciprocal Translocation and COL2A1 Mutation in a Fetus with Severe Skeletal Dysplasia: Implications for Genetic Counseling. Cytogenet Genome Res 145(1):25-8.

Herr D, Bekes I, Wulff C. (2015) Regulation of endothelial permeability in the primate corpora lutea: implications for ovarian hyperstimulation syndrome. Reproduction 149(2):R71-9.

Hummel J, Kämmerer U, Müller N, Avota E, Schneider-Schaulies S. (2015) Human endogenous retrovirus envelope proteins target dendritic cells to suppress T-cell activation. Eur J Immunol 45(6):1748-59.

Jokinen J, Adametz V, Kredel M, Muellenbach RM, Hönig A, Wöckel A, Dietl J, Roewer N, Kranke P. (2015) Spinal anesthesia in high-volume, low-concentration technique for Caesarean sections: Retrospective analysis. Anaesthesist 164(2):108-14.

Kämmerer U, Gires O, Pfetzer N, Wiegering A, Klement RJ, Otto C. (2015) TKTL1 expression in human malign and benign cell lines. BMC Cancer 15:2.

Kumar P, Naumann U, Aigner L, Wischhusen J, Beier CP, Beier D. (2015) Impaired TGF-? induced growth inhibition contributes to the increased proliferation rate of neural stem cells harboring mutant p53. Am J Cancer Res 5(11):3436-45.

Lutz M, Worschech A, Alb M, Gahn S, Bernhard L, Schwab M, Obermeier S, Einsele H, Kämmerer U, Heuschmann P, Klinker E, Otto C, Mielke S. (2015) Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy. Blood 125(2):261-72.

Mariz K, Ingolf JB, Daniel H, Teresa NJ, Erich-Franz S. (2015) The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases. Clin Exp Metastasis 32(8):857-66.

Müller T, Wirbelauer J, Frauenschuh I, Frambach T, Zollner U, Dietl J. (2015) Umbilical Absent and Reverse End-Diastolic Flow Velocity Waveforms Already Present Prior to Viability do not Exclude Long-Term Foetal Surveillance: A Report of Two Cases. Z Geburtshilfe Neonatol 219(2):99-101.

Schmitt J, Eckardt S, Schlegel PG, Sirén AL, Bruttel VS, McLaughlin KJ, Wischhusen J, Müller AM. (2015) Human Parthenogenetic Embryonic Stem Cell-Derived Neural Stem Cells Express HLA-G and Show Unique Resistance to NK Cell-Mediated Killing. Mol Med 21:185-96.

Singer S, Blettner M, Kreienberg R, Janni W, Wöckel A, Kühn T, Felberbaum R, Flock F, Schwentner L, BRENDA II study group. (2015) Breast Cancer Patients' Fear of Treatment: Results from the Multicenter Longitudinal Study BRENDA II. Breast Care 10(2):95-100.

Stüber TN, Künzel EC, Zollner U, Rehn M, Wöckel A, Hönig A. (2015) Prevalence and Associated Risk Factors for Obesity During Pregnancy Over Time. Geburtsh Frauenheilk 75(9):923-928.

Van Ewijk R, Wöckel A, Gundelach T, Hancke K, Janni W, Singer S, Kreienberg R, Blettner M, Schwentner L. (2015) Is guideline-adherent adjuvant treatment an equal alternative for patients aged >65 who cannot participate in adjuvant clinical breast cancer trials? A retrospective multi-center cohort study of 4,142 patients. Arch Gynecol Obstet 291(3):631-40.

Varagnolo L, Lin Q, Obier N, Plass C, Dietl J, Zenke M, Claus R, Müller AM. (2015) PRC2 inhibition counteracts the culture-associated loss of engraftment potential of human cord blood-derived hematopoietic stem and progenitor cells. Sci Rep 5:12319.

Wolters R, Wischhusen J, Stüber T, Weiss CR, Krockberger M, Bartmann C, Blettner M, Janni W, Kreienberg R, Schwentner L, Novopashenny I, Wischnewsky M, Wöckel A, Diessner J. (2015) Guidelines are advantageous, though not essential for improved survival among breast cancer patients. Breast Cancer Res Treat 152(2):357-66.

Zeiner PS, Preusse C, Blank AE, Zachskorn C, Baumgarten P, Caspary L, Braczynski AK, Weissenberger J, Bratzke H, Reiß S, Pennartz S, Winkelmann R, Senft C, Plate KH, Wischhusen J, Stenzel W, Harter PN, Mittelbronn M. (2015) MIF Receptor CD74 is Restricted to Microglia/Macrophages, Associated with a M1-Polarized Immune Milieu and Prolonged Patient Survival in Gliomas. Brain Pathol 25(4):491-504.

Publikationen 2014

Bartmann C, Segerer SE, Rieger L, Kapp M, Sütterlin M, Kämmerer U. (2014) Quantification of the predominant immune cell populations in decidua throughout human pregnancy. Am J Reprod Immunol 71(2):109-19.

Chandran PA, Keller A, Weinmann L, Adel Seida A, Braun M, Andreev K, Fischer B, Horn E, Schwinn S, Junker M, Houben R, Dombrowski Y, Dietl J, Finotto S, Wölfl M, Meister G, Wischhusen J. (2014) The TGF-?-inducible miR-23a cluster attenuates IFN-? levels and antigen-specific cytotoxicity in human CD8+ T cells. J Leukoc Biol 96(4):633-45.

Diessner J, Bruttel V, Stein RG, Horn E, Häusler SF, Dietl J, Hönig A, Wischhusen J. (2014) Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1). Cell Death Dis 5:e1149.

Dietl J. (2014) Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube. Arch Gynecol Obstet 289(2):241-6.

Ebner F, deGregorio N, Vorwerk E, Janni W, Wöckel A, Varga D. (2014) Should a drain be placed in early breast cancer surgery? Breat Care 9(2):116-22.

Engel JB, Honig A, Kapp M, Hahne JC, Meyer SR, Dietl J, Segerer SE. (2014) Mechanisms of tumor immune escape in triple-negative breast cancers (TNBC) with and without mutated BRCA 1. Arch Gynecol Obstet 289(1):141-7.

Frauenschuh I, Frambach T, Karl S, Dietl J, Müller T. (2014) Ductus venosus blood flow prior to intrauterine foetal death in severe placental insufficiency can be unaffected as shown by doppler sonography. Z Geburtshilfe Neonatol 218(5):218-22.

Hahne JC, Meyer SR, Dietl J, Honig A. (2014) The effect of Cordyceps extract and a mixture of Ganoderma lucidum/Agaricus Blazi Murill extract on human endometrial cancer cell lines in vitro. Int J Oncol 45(1):373-82.

Häusler SF, Del Barrio IM, Diessner J, Stein RG, Strohschein J, Hönig A, Dietl J, Wischhusen J. (2014) Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion. Am J Transl Res 6(2):129-39.

Keller A, Leidinger P, Vogel B, Backes C, ElSharawy A, Galata V, Mueller SC, Marquart S, Schrauder MG, Strick R, Bauer A, Wischhusen J, Beier M, Kohlhaas J, Katus HA, Hoheisel J, Franke A, Meder B, Meese E. (2014) miRNAs can be generally associated with human pathologies as exemplified for miR-144. BMC Med 12(1):224.

Knieper C, Ramsauer B, Hancke K, Woeckel A, Ismail L, Bühren A, Toth B. (2014) "Pregnant and Operating": Evaluation of a Germany-wide Survey Among Female Gynaecologists and Surgeons. Geburtsh Frauenheilk 74(9):875-880.

Rieger J, Bähr O, Maurer GD, Hattingen E, Franz K, Brucker D, Walenta S, Kämmerer U, Coy JF, Weller M, Steinbach JP. (2014) ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol 44(6):1843-52.

Siegl C, Prusty BK, Karunakaran K, Wischhusen J, Rudel T. (2014) Tumor suppressor p53 alters host cell metabolism to Limit Chlamydia trachomatis infection. Cell Rep 9(3):918-29.

Stein RG, Meinusch M, Diessner J, Dietl J, Hönig A, Zollner U. (2014) Amniotic fluid insulin and C-peptide as predictive markers for fetal macrosomia, birth injuries, and delivery complications? Med Sci Monit 20:54-8.

Wiegering A, Korb D, Thalheimer A, Kämmerer U, Allmanritter J, Matthes N, Linnebacher M, Schlegel N, Klein I, Ergün S, Germer CT, Otto C. (2014) E7080 (lenvatinib), a multi-targeted tyrosine kinase inhibitor, demonstrates antitumor activities against colorectal cancer xenografts. Neoplasia 16(11):972-81.

Publikationen 2013

Dent S, Oyan B, Honig A, Mano M, Howell S. (2013) HER2-targeted therapy in breast cancer: a systematic review of neoadjuvant trials. Cancer Treat Rev 39(6):622-31.

Diessner J, Bruttel V, Becker K, Pawlik M, Stein R, Häusler S, Dietl J, Wischhusen J, Hönig A. (2013) Targeting breast cancer stem cells with HER2-specific antibodies and natural killer cells. Am J Cancer Res 3(2):211-20.

Diessner J, Stüber T, Niederle B, Pawlik M, Dietl J, Honig A. (2013) XY gonadal dysgenesis--development of a germ cell tumor: case report. Eur J Gynaecol Oncol 34(6):572-4.

Hahne JC, Meyer SR, Gambaryan S, Walter U, Dietl J, Engel JB, Honig A. (2013) Immune escape of AKT overexpressing ovarian cancer cells. Int J Oncol 42(5):1630-5.

Hahne JC, Meyer SR, Kranke P, Dietl J, Guckenberger M, Polat B, Hönig A. (2013) Studies on the role of osteopontin-1 in endometrial cancer cell lines. Strahlenther Onkol 178(12):1040-8.

Hahne JC, Schmidt H, Meyer SR, Engel JB, Dietl J, Honig A. (2013) Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS 126 in models of triple-negative breast cancer. J Cancer Res Clin Oncol 139(6):905-14.

Hennicke F, Grumbt M, Lermann U, Ueberschaar N, Palige K, Böttcher B, Jacobsen ID, Staib C, Morschhäuser J, Monod M, Hube B, Hertweck C, Staib P. (2013) Factors supporting cysteine tolerance and sulfite production in Candida albicans. Eukaryot Cell 12(4):604-13.

Hölters S, Anacker J, Jansen L, Beer-Grondke K, Dürst M, Rubio I. (2013) Tetraspanin 1 promotes invasiveness of cervical cancer cells. Int J Oncol 43(2):503-12.

Klotz D, Frölich K, Zollner U, Rehn M, Wirbelauer J. (2013) Unexpected respiratory distress in the delivery room--a rare differential diagnosis for the obstetrician and neonatologist. Z Geburtshilfe Neonatol 217(4):144-6.

Kranke P, Girard T, Lavand'homme P, Melber A, Jokinen J, Muellenbach RM, Wirbelauer J, Hönig A. (2013) Must we press on until a young mother dies? Remifentanil patient controlled analgesia in labour may not be suited as a "poor man's epidural". BMC Pregnancy Childbirth 13:139.

Palige K, Linde J, Martin R, Böttcher B, Citiulo F, Sullivan DJ, Weber J, Staib C, Rupp S, Hube B, Morschhäuser J, Staib P. (2013) Global transcriptome sequencing identifies chlamydospore specific markers in Candida albicans and Candida dubliniensis. PLoS ONE 18(4):e61940.

Segerer SE, Martignoni F, Bogdan A, Müller N, Kapp M, Dietl J, Rieger L, Kämmerer U. (2013) Thrombopoietin modulates the proliferation, migration and cytokine profile of decidual cell subsets during early gestation. Mol Hum Reprod 19(6):361-8.

Wasem S, Rifai M, Hönig A, Wirbelauer J, Roewer N, Kranke P. (2013) Should opioids be routinely used for the induction of general anaesthesia for caesarean section? Anasthesiol Intensivmed Notfallmed Schmerzther 48(6):374-7.

Zollner KP, Hofmann T, Zollner U. (2013) Good fertilization results associated with high IL-1beta concentrations in follicular fluid of IVF patients. J Reprod Med 58(11-12):485-90.

Zollner U, Dietl J. (2013) Perinatal risks after IVF and ICSI. J Perinat Med 41(1):17-22.

Zollner U, Neumann C, Zollner KP. (2013) Probability of success of conservative treatment of infertility: exact timing as an important prognostic factor. J Reprod Med 58(5-6):205-11.

Publikationen 2012

Bauer B, Majic M, Rauthe S, Bröcker EB, Kerstan A. (2012) Persistent swelling after flushing of an abscess with Octenisept®. Unfallchirurg 115(12):1116-9.

Beier CP, Kumar P, Meyer K, Leukel P, Bruttel V, Aschenbrenner I, Riemenschneider MJ, Fragoulis A, Rümmele P, Lamszus K, Schulz JB, Weis J, Bogdahn U, Wischhusen J, Hau P, Spang R, Beier D. (2012) The cancer stem cell subtype determines immune infiltration of glioblastoma. Stem Cells Dev 21(15):2753-61.

Engel JB, Hahne JC, Häusler SF, Meyer S, Segerer SE, Diessner J, Dietl J, Honig A. (2012) Peptidomimetic GnRH antagonist AEZS-115 inhibits the growth of ovarian and endometrial cancer cells. Anticancer Res 32(5):2063-8.

Engel JB, Martens T, Hahne JC, Häusler SF, Krockenberger M, Segerer S, Djakovic A, Meyer S, Dietl J, Wischhusen J, Honig A. (2012) Effects of lobaplatin as a single agent and in combination with TRAIL on the growth of triple-negative p53-mutated breast cancers in vitro. Anticancer Drugs 23(4):426-36.

Hahne JC, Honig A, Meyer SR, Gambaryan S, Walter U, Wischhusen J, Häussler SF, Segerer SE, Fujita N, Dietl J, Engel JB. (2012) Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro. Oncol Rep 28(6):2023-8.

Hassold N, Seystahl K, Kempf K, Urlaub D, Zekl M, Einsele H, Watzl C, Wischhusen J, Seggewiss-Bernhardt R. (2012) Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib. Int J Cancer131(6):E916-27.

Häusler SF, Bernar T, Rau S, Kranke P, Dietl J, Rieger L. (2012) Severe maternal hepatopathies in the peripartum period--a case series with review of the literature focusing on pathogenesis and differential diagnosis. Z Geburtshilfe Neonatol 216(6):277-84.

Honig A, Hahne JC, Meyer S, Kranke P, Häusler S, Diessner J, Dietl J, Engel JB. (2012) PI3K inhibitor D-116883 is effective in in vitro models of ovarian cancer. Anticancer Res 32(5):2035-41.

Klingelhoeffer C, Kämmerer U, Koospal M, Mühling B, Schneider M, Kapp M, Kübler A, Germer CT, Otto C. (2012) Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress. BMC Complement Altern Med 12:61.

Krockenberger M, Kranke P, Häusler S, Engel JB, Horn E, Nürnberger K, Wischhusen J, Dietl J, Hönig A. (2012) Macrophage migration-inhibitory factor levels in serum of patients with ovarian cancer correlates with poor prognosis. Anticancer Res 32(12):5233-8.

Segerer SE, Rieger L, Kapp M, Dombrowski Y, Müller N, Dietl J, Kämmerer U. (2012) MIC-1 (a multifunctional modulator of dendritic cell phenotype and function) is produced by decidual stromal cells and trophoblasts. Hum Reprod 27(1):200-9.

Segerer SE, Staib C, Kaemmerer U, Frambach T, Honig A, Dietl J, Rieger L. (2012) Dendritic cells: elegant arbiters in human reproduction. Curr Pharm Biotechnol 13(8):1378-84.

Stein RG, Diessner J, Frieauff E, Zollner U, Rehn M, Dietl J, Hönig A. (2012) Acute foeto-foetal transfusion syndrome--case report and review of the literature. Z Geburtshilfe Neonatol 216(3):147-9.

Zollner U, Rehn M, Girschick G, Dietl J. (2012) Sonographic abnormalities of the fetal CNS in the second trimester screening--clarifications according to the new maternity directives. Z Geburtshilfe Neonatol 216(1):1-10.

Zollner U, Rehn M, Heuer S, Morr AK, Dietl J. (2012) Umbilical cord entanglement in monoamniotic twins. Ultrasound Obstet Gynecol 40(1):121-2.

Zollner U, Specketer MT, Dietl J, Zollner KP. (2012) 3D-Endometrial volume and outcome of cryopreserved embryo replacement cycles. Arch Gynecol Obstet 286(2):517-23.

Kontakt, Öffnungszeiten, Sprechzeiten

Telefon:

Auskunft / Pforte:
+49 931 201-25253 oder
+49 931 201-25621

Fax:

+49 931 201-25406


Anschrift:

Frauenklinik und Poliklinik des Universitätsklinikums | Josef-Schneider-Str. 4 | Haus C15 | 97080 Würzburg | Deutschland